September 20, 2016
Newly Published Study Finds NARCAN® Nasal Spray’s Concentrated Formulation Rapidly Delivers an Effective Naloxone Dose and is Readily Usable by the General Public...
July 12, 2016
Adapt Pharma to Launch Program to Raise Awareness, Expand Access and Facilitate Product Experience of NARCAN® (Naloxone HCl) Nasal Spray - a new Treatment for Opioid Overdose...
July 6, 2016
Earlier today, Health Canada announced it will establish temporary access to the only U.S. Food and Drug Administration (FDA) approved, intranasal version of naloxone, NARCAN® Nasal Spray, the medicat...
May 2, 2016
Adapt Pharma submits NDS to Health Canada for Naloxone Nasal Spray...
April 28, 2016
Today, high schools across the country can join their communities in the battle against the opioid epidemic...
April 14, 2016
Introducing the NARCAN® Now App, a smartphone application providing opioid overdose recognition education and treatment instructions...
April 11, 2016
Adapt Pharma Names Mike Kelly President of U.S. Operations. Contributing Over 25 Years of Pharmaceutical Expertise to Adapt Executive Team...
February 25, 2016
Adapt Pharma, Limited (www.adaptpharma.com) today announced the United States (U.S.) commercial availability of NARCAN® (Naloxone Hydrochloride) Nasal Spray...
January 25, 2016
Adapt Pharma to offer all U.S. high schools a free NARCAN® Nasal Spray...
January 14, 2016
Adapt Pharma facilitates NARCAN® (naloxone hydrochloride) Nasal Spray access to state and local public entities...
November 19, 2015
NARCAN® (naloxone hydrochloride) Nasal Spray approved by U.S. food and drug administration...
September 24, 2015
FDA accepts for review Adapt Pharma’s NARCAN® (naloxone hydrochloride) Nasal Spray NDA...
July 27, 2015
Adapt Pharma submits NDA to FDA for NARCAN® (Naloxone) Nasal Spray...
July 2, 2015
Adapt Pharma acquires NARCAN NDA and obtains license to the NARCAN® trademark...
June 3, 2015
Adapt Pharma Commences Rolling NDA Submission to the FDA for Intranasal Naloxone...
April 22, 2015
Adapt Pharma Announces Successful Completion of Intranasal Naloxone Study...
February 17, 2015
Adapt Pharma Announces Fast Track Designation From FDA for Naloxone Nasal Spray...
January 5, 2015
Adapt Pharma and Profector Life Sciences Enter a Development and Investment Collaboration...
December 16, 2014
Adapt Pharma Announces License Agreement for Naloxone Nasal Spray With Lightlake Therapeutics Inc....
May 2, 2014
Adapt Pharma Completes $95 Million Equity Financing U.S. Focused Specialty Pharmaceutical Company...